Metabolic Health comparison
Find your weight-care fit.
Three approaches to appetite and food noise—made easier to understand.
At a glance
See what feels like you.
Swipe to compare →
Evvie option
Semaglutide
Turn down the food noise.
Evvie option
Tirzepatide
Two pathways. One clear goal.
Evvie option
GLP-1 Microdosing
Ease into GLP-1 support.
Designed for
People who want cravings to feel quieter and meals to feel more intentional.
People who want broader support for appetite, weight, and metabolic health.
People curious about GLP-1 care who are not ready to go all in.
Best understood as
The familiar, well-studied GLP-1 path.
A once-weekly medication that works across two metabolic pathways.
A lower-dose, provider-guided starting approach.
Why people choose it
They want a trusted starting point with a simple once-weekly routine.
They want stronger appetite support from a dual-action approach.
They want a measured start with more room to adjust.
What makes it different
Works through one GLP-1 pathway and has extensive clinical-study data.
Targets GIP and GLP-1 and produced greater average weight loss in clinical trials than semaglutide. Individual results vary.
Lower doses, gradual adjustments, and a plan guided by how you respond.
Good to know
Dose adjustments are guided by progress and how you feel.
The right starting point depends on your history and goals.
A lower-dose approach for steadier appetite support.
The easy answer
Choose Semaglutide for the established GLP-1 path, Tirzepatide for dual-action support, or Microdosing for a lower-and-slower start.
Prescription treatment requires a medical intake and provider approval. Individual results vary.